ArticleJournal of thoracic disease2025

Efficacy and safety of immune checkpoint inhibitors in EGFR-mutant NSCLC patients with EGFR-TKI resistance: an updated systematic review and meta-analysis.

Xiaojing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.